Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Toro Neurovascular, Inc. currently has 1 pending office action in the Medical Devices & Mechanical Engineering technology area. This matter is assigned to 1 distinct examiner and 1 distinct art unit. This level of concentration indicates that the company's current prosecution is focused on a single technical application within a specific USPTO art unit.
NEERAJA GOLLAMUDI is the busiest examiner for the portfolio, holding 1 pending office action. This examiner is responsible for the entirety of the company's active prosecution. For a practitioner, this means that the success of the current patent strategy in the Medical Devices & Mechanical Engineering field depends on the specific examination style of NEERAJA GOLLAMUDI and the guidelines of the 1 distinct art unit.
Because there is 1 pending office action, there is no distribution of work across different examiners. The company's immediate patent goals are centralized within this one proceeding. This focused approach means that the practitioner can devote all resources to addressing the specific requirements of the 1 distinct examiner and art unit involved in the case.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GOLLAMUDI, NEERAJA | 1 | 72.8% | +40.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18926031 | REINFORCED CATHETER DESIGN WITH IMPROVED FLEXIBILITY | GOLLAMUDI, NEERAJA | — |
| Art Unit | Apps |
|---|---|
| 3783 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18926031 | REINFORCED CATHETER DESIGN WITH IMPROVED FLEXIBILITY | GOLLAMUDI, NEERAJA | 3783 | §103 | Non-Final OA | — | Pending | Oct 24, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialToro Neurovascular, Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Neeraja Gollamudi has the most, with 1 of Toro Neurovascular, Inc.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.